UBS Group Analysts Give Apple (NASDAQ:AAPL) a $180.00 Price Target
UBS Group Analysts Give Apple (NASDAQ:AAPL) a $180.00 Price Target。
UBS Group Analysts Give Apple (NASDAQ:AAPL) a $180.00 Price Target Read Post »
UBS
UBS raised Meta Platforms (NASDAQ:META) price target to $280
UBS analyst Lloyd Walmsley maintains Meta Platforms (NASDAQ:META) with a Buy and raises the price target from $235 to $280.
UBS raised Meta Platforms (NASDAQ:META) price target to $280 Read Post »
UBS raised PepsiCo (NASDAQ:PEP) price target to $205
UBS analyst Peter Grom maintains PepsiCo (NASDAQ:PEP) with a Buy and raises the price target from $195 to $205.
UBS raised PepsiCo (NASDAQ:PEP) price target to $205 Read Post »
UBS raised Procter & Gamble (NYSE:PG) price target to $170
UBS analyst Peter Grom maintains Procter & Gamble (NYSE:PG) with a Buy and raises the price target from $163 to $170.
UBS raised Procter & Gamble (NYSE:PG) price target to $170 Read Post »
UBS lowered Estee Lauder (NYSE:EL) price target to $278
UBS analyst Peter Grom maintains Estee Lauder Cos (NYSE:EL) with a Neutral and lowers the price target from $290 to $278.
UBS lowered Estee Lauder (NYSE:EL) price target to $278 Read Post »
UBS raised Alphabet (NASDAQ:GOOG) price target to $123
UBS analyst Lloyd Walmsley maintains Alphabet (NASDAQ:GOOG) with a Buy and raises the price target from $120 to $123.
UBS raised Alphabet (NASDAQ:GOOG) price target to $123 Read Post »
UBS announced Intuitive Surgical (NASDAQ:ISRG) Price Target of $278
UBS analyst Danielle Antalffy initiates coverage on Intuitive Surgical (NASDAQ:ISRG) with a Neutral rating and announces Price Target of $278.
UBS announced Intuitive Surgical (NASDAQ:ISRG) Price Target of $278 Read Post »
UBS raised Lululemon Athletica (NASDAQ:LULU) price target from $335 to $399
UBS analyst Jay Sole maintains Lululemon Athletica (NASDAQ:LULU) with a Neutral and raises the price target from $335 to $399.
UBS raised Lululemon Athletica (NASDAQ:LULU) price target from $335 to $399 Read Post »
UBS raiseed Colgate-Palmolive (NYSE:CL) price target from $84 to $86
UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $84 to $86.
UBS raiseed Colgate-Palmolive (NYSE:CL) price target from $84 to $86 Read Post »
UBS announced Abbott Laboratories (NYSE:ABT) Price Target of $117
UBS analyst Danielle Antalffy assumes Abbott Laboratories (NYSE:ABT) with a Buy rating and announces Price Target of $117.
UBS announced Abbott Laboratories (NYSE:ABT) Price Target of $117 Read Post »
UBS Adjusts Ross Stores (NASDAQ:ROST) Price Target to $77 From $117
UBS Downgrades Ross Stores (NASDAQ:ROST) to Sell From Neutral, Adjusts Price Target to $77 From $117.
UBS Adjusts Ross Stores (NASDAQ:ROST) Price Target to $77 From $117 Read Post »
UBS Adjusts Medtronic (NYSE:MDT) Price Target to $79 From $127
UBS Downgrades Medtronic (NYSE:MDT) to Sell From Buy, Adjusts Price Target to $79 From $127
UBS Adjusts Medtronic (NYSE:MDT) Price Target to $79 From $127 Read Post »